Literature DB >> 24616545

Merkel cell carcinoma, version 1.2014.

Christopher K Bichakjian, Thomas Olencki, Murad Alam, James S Andersen, Daniel Berg, Glen M Bowen, Richard T Cheney, Gregory A Daniels, L Frank Glass, Roy C Grekin, Kenneth Grossman, Alan L Ho, Karl D Lewis, Daniel D Lydiatt, William H Morrison, Kishwer S Nehal, Kelly C Nelson, Paul Nghiem, Clifford S Perlis, Ashok R Shaha, Wade L Thorstad, Malika Tuli, Marshall M Urist, Timothy S Wang, Andrew E Werchniak, Sandra L Wong, John A Zic, Karin G Hoffmann, Nicole R McMillian, Maria Ho.   

Abstract

Merkel cell carcinoma is a rare, aggressive cutaneous tumor that combines the local recurrence rates of infiltrative nonmelanoma skin cancer with the regional and distant metastatic rates of thick melanoma. The NCCN Guidelines for Merkel Cell Carcinoma provide recommendations on the diagnosis and management of this aggressive disease based on clinical evidence and expert consensus. This version includes revisions regarding the use of PET/CT imaging and the addition of a new section on the principles of pathology to provide guidance on the analysis, interpretation, and reporting of pathology results.

Entities:  

Mesh：

Year:  2014        PMID： 24616545      PMCID： PMC9441108          DOI： 10.6004/jnccn.2014.0041

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   12.693


  58 in total

1.  Merkel cell carcinoma.

Authors:  Stanley J Miller; Murad Alam; James Andersen; Daniel Berg; Christopher K Bichakjian; Glen Bowen; Richard T Cheney; Frank Glass; Roy C Grekin; James M Grichnik; Timothy M Johnson; Anne Kessinger; Nancy Y Lee; Stuart Lessin; Daniel D Lydiatt; Lawrence W Margolis; Kishwer S Nehal; Paul Nghiem; Allan R Oseroff; E William Rosenberg; Ashok R Shaha; Ronald J Siegle
Journal:  J Natl Compr Canc Netw       Date:  2006-08       Impact factor: 11.908

2.  Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study.

Authors:  T Jouary; C Leyral; B Dreno; A Doussau; B Sassolas; M Beylot-Barry; C Renaud-Vilmer; B Guillot; P Bernard; C Lok; C Bedane; F Cambazard; L Misery; E Estève; S Dalac; L Machet; F Grange; P Young; F Granel-Brocard; F Truchetet; B Vergier; M M Delaunay; J J Grob
Journal:  Ann Oncol       Date:  2011-07-12       Impact factor: 32.976

3.  New virus associated with merkel cell carcinoma development.

Authors:  Dana E Rollison; Anna R Giuliano; Jürgen C Becker
Journal:  J Natl Compr Canc Netw       Date:  2010-08       Impact factor: 11.908

Review 4.  Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases.

Authors:  P T Tai; E Yu; E Winquist; A Hammond; L Stitt; J Tonita; J Gilchrist
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

5.  Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes.

Authors:  Lyndon D Su; Lori Lowe; Carol R Bradford; Alan I Yahanda; Timothy M Johnson; Vernon K Sondak
Journal:  J Am Acad Dermatol       Date:  2002-05       Impact factor: 11.527

6.  Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients.

Authors:  W J O'Connor; R K Roenigk; D G Brodland
Journal:  Dermatol Surg       Date:  1997-10       Impact factor: 3.398

7.  Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin.

Authors:  Priya Rao; Bonnie L Balzer; Bianca D Lemos; Nanette J Liegeois; Jennifer M McNiff; Paul Nghiem; Victor G Prieto; M Timothy Smith; Bruce Robert Smoller; Mark R Wick; David P Frishberg
Journal:  Arch Pathol Lab Med       Date:  2010-03       Impact factor: 5.686

8.  Positron emission tomography/computed tomography imaging in Merkel cell carcinoma: a study of 270 scans in 97 patients at the Dana-Farber/Brigham and Women's Cancer Center.

Authors:  Elena B Hawryluk; Kevin N O'Regan; Niall Sheehy; Ye Guo; Andrew Dorosario; Christopher G Sakellis; Heather A Jacene; Linda C Wang
Journal:  J Am Acad Dermatol       Date:  2012-11-03       Impact factor: 11.527

9.  18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience.

Authors:  Shankar Siva; Keelan Byrne; Matthew Seel; Mathias Bressel; Daphne Jacobs; Jason Callahan; Joshua Laing; Michael P Macmanus; Rodney J Hicks
Journal:  J Nucl Med       Date:  2013-06-10       Impact factor: 10.057

10.  Imaging in patients with merkel cell carcinoma.

Authors:  Elisabeth Enzenhofer; Philipp Ubl; Christian Czerny; Boban M Erovic
Journal:  J Skin Cancer       Date:  2013-02-06
View more
  16 in total

1.  Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study.

Authors:  Kelly G Paulson; Christopher W Lewis; Mary W Redman; William T Simonson; Aaron Lisberg; Deborah Ritter; Chihiro Morishima; Kathleen Hutchinson; Lola Mudgistratova; Astrid Blom; Jayasri Iyer; Ata S Moshiri; Erica S Tarabadkar; Joseph J Carter; Shailender Bhatia; Masaoki Kawasumi; Denise A Galloway; Mark H Wener; Paul Nghiem
Journal:  Cancer       Date:  2016-12-07       Impact factor: 6.860

Review 2.  A case series and literature review of Merkel cell carcinoma metastasizing to pancreas.

Authors:  Yezaz A Ghouri; Somashekar G Krishna; Uma R Kundu; Manoop S Bhutani; Manoop S Butani; Jeffrey H Lee; William A Ross
Journal:  Dig Dis Sci       Date:  2015-01-14       Impact factor: 3.199

3.  Interaction between Merkel cell carcinoma and the immune system: Pathogenetic and therapeutic implications.

Authors:  Irene Zanetti; Ilaria Coati; Mauro Alaibac
Journal:  Mol Clin Oncol       Date:  2017-09-01

4.  Merkel cell carcinoma: Epidemiology, disease presentation, and current clinical practice outcomes.

Authors:  Marita Yaghi; Paul Benedetto; John Greskovich; Roger Haber; Barbara Dominguez; Hong Liang; Zeina Nahleh; Rafael Arteta-Bulos
Journal:  JAAD Int       Date:  2022-06-17

5.  Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?

Authors:  Matthew C Perez; Felipe R de Pinho; Amanda Holstein; Daniel E Oliver; Syeda M H Naqvi; Youngchul Kim; Jane L Messina; Erin Burke; Ricardo J Gonzalez; Amod A Sarnaik; C Wayne Cruse; Evan J Wuthrick; Louis B Harrison; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2018-08-02       Impact factor: 5.344

6.  Co-expression of NGF and PD-L1 on tumor-associated immune cells in the microenvironment of Merkel cell carcinoma.

Authors:  Ulrike Wehkamp; Sophie Stern; Sandra Krüger; Michael Weichenthal; Axel Hauschild; Christoph Röcken; Friederike Egberts
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-09       Impact factor: 4.553

7.  Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers.

Authors:  Kelly L Harms; Lili Zhao; Bryan Johnson; Xiaoming Wang; Shannon Carskadon; Nallasivam Palanisamy; Daniel R Rhodes; Rahul Mannan; Josh N Vo; Jae Eun Choi; May P Chan; Douglas R Fullen; Rajiv M Patel; Javed Siddiqui; Vincent T Ma; Steven Hrycaj; Scott A McLean; Tasha M Hughes; Christopher K Bichakjian; Scott A Tomlins; Paul W Harms
Journal:  Clin Cancer Res       Date:  2021-02-05       Impact factor: 12.531

8.  Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience.

Authors:  Evan Liang; Jeffrey V Brower; Stephanie R Rice; Darya G Buehler; Sandeep Saha; Randall J Kimple
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

9.  Frequency and locations of systemic metastases in Merkel cell carcinoma by imaging.

Authors:  Maria Kouzmina; Virve Koljonen; Junnu Leikola; Tom Böhling; Eila Lantto
Journal:  Acta Radiol Open       Date:  2017-03-24

10.  Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System.

Authors:  Kelly L Harms; Mark A Healy; Paul Nghiem; Arthur J Sober; Timothy M Johnson; Christopher K Bichakjian; Sandra L Wong
Journal:  Ann Surg Oncol       Date:  2016-05-19       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.